There is great geographical variation in the distribution of hepatocellular carcinoma (HCC),
with the majority of all cases worldwide found in the Asia–Pacific region, where HCC is one …

Staging and treatment indication are relevant topics in the management of patients with
hepatocellular carcinoma (HCC) and for optimal results, they have to take into account liver …

OBJECTIVES: Radiofrequency ablation (RFA) is widely performed for hepatocellular
carcinoma (HCC). However, there has been no report on 10-year outcome of RFA. The …

Background & Aims Both hepatic resection and radiofrequency ablation (RFA) are
considered curative treatments for hepatocellular carcinoma (HCC), but their economic …

Hepatobiliary cancers are highly lethal. In 2008, approximately 21,370 persons in the United
States were estimated to be diagnosed with liver or intrahepatic bile duct cancer and 9520 …

BACKGROUND & AIMS: The aim of this study was to compare liver resection and
radiofrequency ablation in patients with single hepatocellular carcinoma⩽ 3cm and …

Background Despite being one of the commonest causes of cancer-related death around
the world, only 20 per cent of hepatocellular carcinomas (HCCs) are amenable to curative …

Image‐guided percutaneous ablation is considered best in the treatment of early‐stage
hepatocellular carcinoma (HCC). Ablation is potentially curative, minimally invasive, and …

BACKGROUND: Early recurrence (ER)(< 1 year) after liver resection is one of the most
important factors that impact the prognosis of patients with hepatocellular carcinoma (HCC) …

Objectives To evaluate the efficacy and safety of radiofrequency ablation (RFA) versus
hepatic resection (HR) for early hepatocellular carcinoma (HCC) meeting the Milan criteria …